N/A
Completed N=125
Exploring the Effects of Muse and Spire on Stress Management
Source: ClinicalTrials.gov NCT02786771 ↗Enrolled (actual)
125
Serious AEs
0.0%
Results posted
May 2018
Primary outcomePrimary: Difference in Perceived Stress and Stress Resilience From Enrollment to Closeout — 20.24; 19.15; 23.59; 22.49 units on a scale
Summary
The goal of this study is to evaluate the effectiveness of Spire and Muse on stress management. The study will be implemented as a 2-arm randomized controlled pilot study to assess the effect of either device on stress management from the end of baseline to closeout.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Difference in Perceived Stress and Stress Resilience From Enrollment to Closeout |
20.24; 19.15; 23.59; 22.49; 68.25; 70.00 | — |
Eligibility Criteria
Inclusion Criteria
- Registered for Partners HealthCare Connected Health Symposium 2016
- Over 18 years old
- Able to read and speak English
- Own a smartphone and have internet connection
- Willing to wear a Spire device during all hours (except sleep)
- Willing to use the Muse device (Group 2 ONLY)
- Willing to participate in a research study and sign the consent form
Exclusion Criteria
- Not Registered for Partners HealthCare Connected Health Symposium 2016
- Under 18 years old
- Not able to read and speak English
- Do not own a smartphone and have internet connection
- Not willing to wear a Spire device during all hours (except sleep)
- Not willing to use the Muse device (Group 2 ONLY)
- Not willing to sign the consent form
Data sourced from ClinicalTrials.gov (NCT02786771). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.